Please login to the form below
infectious diseases
This page shows the latest infectious diseases news and features for those working in and with pharma, biotech and healthcare.
EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
as ‘point-of-care’ tests, to detect and characterise a variety of diseases within minutes.
Latest news
-
Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
of Allergy and Infectious Diseases (NIAID). ... platforms in both oncology and infectious diseases,” he added.
-
CDC provides $262.5m to create national network for infectious diseases
Infectious diseases, such as tuberculosis and lyme disease, are illnesses that are caused by germs, including bacteria, viruses and fungi, that cause infection upon entering the body. ... health; and prepare for and respond to infectious disease threats.
-
Pfizer’s Abrysvo RSV vaccine recommended by US CDC for infants
This [autumn] marks the start of the annual respiratory infection season in the Northern Hemisphere, and we are prepared with vaccines against multiple infectious diseases and – for the first time in
-
Gilead’s Veklury recommended by CHMP for COVID-19 in patients with hepatic impairment
an increased risk of complications from COVID-19,” said Antonella Castagna, head of infectious diseases at San Raffaele Scientific Institute and professor, clinic of infectious diseases at Vita-Salute San Raffaele
-
CSL Seqirus highlights impact of flu vaccines on reducing strain on healthcare resources
Joaquin Mould-Quevedo, global HEOR and value strategy director at CSL Seqirus, said: "In a world where healthcare systems are laser-focused on enhancing the prevention of infectious diseases, vaccination
More from news
Approximately 20 fully matching, plus 296 partially matching documents found.
Latest Intelligence
-
Rare diseases: not so rare after all
New approaches. Historically, the small case numbers of rare diseases have led to their neglect. ... With recent advances, the range of disease areas has expanded and now includes very different indications, ranging from ophthalmology to infectious
-
The challenges of identifying rare diseases
Several factors contribute to the difficulty of accurately identifying and counting rare diseases. ... After excluding rare cancers, infectious diseases and poisonings, this study estimated that 262.9 to 446.2 million people worldwide are affected by a
-
Future-proofing pharma supply chains by improving inefficiencies in global health architecture
But this has come at the expense of efforts to address other emerging infectious diseases (EIDs), including the running of clinical trials. ... Recent evidence for this growing support includes GSK’s announcement of a £1bn investment over ten years to
-
The fight against antimicrobial resistance
Several common respiratory diseases, including Streptococcus pneumoniae and Haemophilus influenzae, show reduced susceptibility to several classes of antibiotics. ... we are to avoid a surge of untreatable infectious diseases.
-
Paving the way for representation in clinical trials
EM-90081 March 2022. Lee-Ann Farrell is Vaccines Lead and Dr Mohamed Lockhat is Medical Director, Infectious Diseases and Vaccines, both at Janssen UK. . ... Lee-Ann Farrell is Vaccines Lead and Dr Mohamed Lockhat is Medical Director, Infectious Diseases
More from intelligence
Approximately 0 fully matching, plus 33 partially matching documents found.
Latest appointments
-
Evoke KYNE promotes Dante DelVecchio to senior VP
In his new role, he will become a member of the firm’s senior management team, and will continue to oversee key client engagements in infectious diseases, vaccines and immuno-oncology.
-
New faces at HCA, P\S\L Group and Health Unlimited
Over her 15-year career, Peck has worked across a range of healthcare communications areas, including oncology, dermatology, infectious diseases and more.
-
New hires at Bayer, Eisai and Accord Healthcare
Most recently, she held the position of vice president of M&A operations and divestitures and led the infectious diseases and vaccines business development. ... She joins Eisai from Merck, where she served as executive director, clinical quality assurance
-
Immunocore names new CEO, Nanoform adds to commercial team and Verona hires CMO
and infectious diseases.
-
Nabriva Therapeutics appoints chief medical officer
Commenting on the appointment, Dr Colin Broom, chief executive officer of Nabriva, said: “Jennifer has broad expertise in infectious diseases and internal medicine with extensive experience in both clinical development and
More from appointments
Approximately 0 fully matching, plus 38 partially matching documents found.
Latest from PMHub
-
Article: Could combating stigma increase the uptake of PrEP and finally end the HIV epidemic?
In this article we explore what more could be done by the pharmaceutical industry to help prevent the spread of HIV infection worldwide. The advancement of treatment for HIV since the 1980s when the epidemic began has been rapid, but beyond the pill,
-
How the WHO hepatitis strategy measures up in the field
Despite the availability of treatment options to manage hepatitis B and cure hepatitis C, people across the globe are dying from both diseases. ... Indeed, one of the main barriers to treating these diseases is that a high proportion of patients are part
-
Medscape Education Global
Rare diseases: making a difference through education.
-
Improving healthcare for rare disease patients
4. but there are also rare infectious diseases, rare forms of cancer and more. ... Joszt L. Not So Rare: 300 Million People Worldwide Affected by Rare Diseases.
-
Wearable Technologies for Detecting Pre-Symptomatic Illness and Infections
Tejaswini Mishra, Research Scientist at Stanford University School of Medicine, dives into her research on using wearable technologies for detecting COVID-19 and other diseases before patients become symptomatic. ... Among other things, she discusses
More from PMHub
Approximately 4 fully matching, plus 13 partially matching documents found.
Subscribe to our email news alerts
- Contagious Conversations: Exploring Infectious Disease in the Digital Age
- Austrian State Secretary to speak at FlyPharma Europe 2023
- Further data for AstraZeneca/Daichii Sankyo’s Enhertu for breast cancer requested by NICE
- Gritstone Bio receives $433m BARDA contract for COVID-19 vaccine candidate
- EDX Medical Group develops multi-disease 'point-of-care' rapid tests for cancer, infections and cardiovascular conditions
- ScreenPoint Medical to showcase AI software at European scientific meeting
No results were found
PMHub
Sciterion
Sciterion is an award winning specialist healthcare communications consultancy within the Havas Health network of companies. We exist to make...
Latest intelligence
- The importance of accelerating clinical trial diversity
- Diversity shouldn’t be an afterthought – it’s an investment in the credibility of scientific endeavour...
- Digital Opinion Leaders: The Role of Influencers in Medical Communications
- There are many informed, knowledgeable HCPs who talk about a disease state online, but not all of them are influencers. This paper explores who digital opinion leaders are and how...
- Creating Hope Though Action – World Suicide Prevention Day
- At Mednet Group, we believe that actions speak louder than words. That's why we're getting behind this year's Suicide Prevention Day campaign of 'creating hope through action'....
